ArticleMolecular neurobiology2025
GABAergic MicroRNA-34a in the Dorsal Raphe Nuclei Contributes to Circulating MicroRNA-34a Levels.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Brain microRNAs (miRs) are expressed in a cell-specific manner and are implicated in several pathologies. Despite circulating miRs (c-miRs) being increasingly recognized as biomarkers of brain disorders, few studies have directly linked specific brain regions or cell types to plasma miR levels under physiological conditions. In the dorsal raphe nuclei (DRN), mir-34a is selectively expressed in GABAergic neurons. This expression increases following prolonged stimuli that challenge DRN activity, like repeated stress or chronic SSRI administration. Here, we investigate whether plasma levels of miR-34a can serve as peripheral indicators of its expression in the DRN. In mice exposed to repeated social defeat stress or chronic SSRIs administration, we observed a significant increase in plasma miR-34a levels, suggesting that DRN homeostatic changes are reflected in c-miR profiles. To identify the source of plasma miR-34a, we employed a genetic approach enabling selective deletion of miR-34a in GABAergic neurons. This resulted in a marked reduction of miR-34a in both DRN and plasma, but not in other brain regions, demonstrating that DRN GABAergic neurons are the main contributors to c-miR-34a. Complementarily, intra-DRN infusion of AntagomiR-34a reproduced the reduction in plasma miR-34a, confirming the DRN as a key anatomical source. Strikingly, the same infusion reduced miR-34a expression in ependymal cells of the choroid plexus, suggesting a potential route of miR-34a from brain to periphery. These findings establish that plasma miR-34a reflects miR-34a expression in DRN GABAergic neurons and demonstrate that c-miRs can report homeostatic adaptations of a defined neuronal population within a specific brain region.
Indexed as
Identifiers
41413742What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.